BNC Wealth Management’s Labcorp LH Stock Holding History

BNC Wealth Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-208	Closed	-$34K	–	308
2020 Q3	$34K	Buy	+208	New	+$33K	0.02%	187

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNC Wealth Management's LH Position: Q4 2020 in Review

BNC Wealth Management sold out of Labcorp (LH) in Q4 2020, closing a stake of 208 shares — an estimated $34K sold.

BNC Wealth Management first reported a position in LH in Q3 2020 and held it in 1 quarter. The position peaked at $34K in Q3 2020. 906 funds tracked by Wall St. Rank hold LH as of Q4 2020.

BNC Wealth Management reported no remaining Labcorp position as of Q4 2020 after selling out during the quarter.
BNC Wealth Management sold 208 Labcorp shares in Q4 2020, an estimated $34K.
BNC Wealth Management first reported a position in Labcorp in Q3 2020 and held it in 1 quarter.
BNC Wealth Management's Labcorp position peaked at $34K in Q3 2020.
906 funds tracked by Wall St. Rank held Labcorp as of Q4 2020.

Based on BNC Wealth Management's 13F filing for Q4 2020, filed 5 Mar 2021.